Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. Amicus' press releases are ...ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
... investor relations section of the Company's Web site at www.adventrx.com . A 48-hour ... webcast will be available on the Company's Web site for 14 days following the completion of the call. ... information can be found on the Company's web site at www.adventrx.com . ...AIAG and MichBio Form New Collaborative Partnership
... AIAG's initiatives visit the organization's Web site at www.aiag.org . About AIAG AIAG is a ... information, please visit the organization's Web site at www.aiag.org . About MichBio MichBio is ... information, please visit the organization's Web site at www.michbio.org . ### Read the full ...ERT Reports Second Quarter 2009 Results
... Financial and can be accessed at ERT's web site at www.ert.com . The webcast may also be ... 26,763 16,215 51,358 32,323 site support 7,222 6,878 ... 10,185 7,671 20,448 15,364 Cost of site support 4,599 3,470 9,867 ...Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date
... investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. Amicus' press releases are ...Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results
... webcast can be accessed from Varian, Inc.'s Web site at www.varianinc.com . Go to ... webcast will be available on Varian, Inc.'s Web site for at least 90 days. Varian, Inc. is a ... information is available on the company's Web site at http://www.varianinc.com . ...American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
... of America. Allergy Facts and Figures. Web site accessed May 1, 2009: ... Allergic Diseases Resource Center. Web site accessed May 26, 2009: ... as a basis for effective treatment." Web site accessed July 1, 2009: ...I Walk Because Program Gives Consumers a Voice
... component of the "I Walk Because" program. The site delivers a personalized user experience through ... for others in the MS community. To keep the site active, registered users also receive a series of emails inviting them back to the site to view content from other walk participants and ...Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy
... an in situ remedial design for a large, complex site located inside an operating petrochemical plant ... Northern Italy. The subsurface environment at the site is impacted by 1,2-dichloroethane (1,2-DCA) and ... 1,2-DCA. CONCLUSIONS Design of full-scale site remediation using the EHC ISCR technology is ...New Stem Cell Web Site to Focus on Traumatic Brain Injury, Spinal Cord Injury and Diabetes
... BMSN) announced today the launch of its Web site ( http://www.EntestBio.com ) to focus on new ... the U.S. suffer from this disability. The site also highlights the Company's progress in ... about types of stem cells and factoids, the new site also reviews Entest BioMedical's focus on the ...ERT Reports First Quarter 2009 Results
... Financial and can be accessed at ERT's web site at www.ert.com . The webcast may also be ... 25,273 16,817 site support 7,775 ... 10,514 7,954 Cost of site support 5,268 ...Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
... investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. Amicus' press releases are ...Bio Career Center Becomes Top in Nation for Life Sciences Careers
... time and shorten the hiring process. The site has become an industry leader because it offers ... needs. "Since all of the candidates on our site are postgraduate life scientists and M.D.s, we know they have a passion for science," said site founder Nick Folger. "More than 40 percent of our ...Hovione Opens its New API Plant in Cork
... active pharmaceutical ingredient manufacturing site in Cork. Hovione contracted with Pfizer last December to take over the site that had been manufacturing Lipitor(R) since ... developer and manufacturer and the Cork site will be used to produce active pharmaceutical ...Varian, Inc. to Webcast Conference Call on Second Quarter Fiscal Year 2009 Financial Results
... webcast can be accessed from Varian, Inc.'s Web site at www.varianinc.com . Go to ... webcast will be available on Varian, Inc.'s Web site for at least 90 days. Varian, Inc. is a ... information is available on the company's Web site at http://www.varianinc.com . For ...Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
... Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction with the ... Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction of the ... from the Investors section on the corporate web site at http://www.sinovac.com . A webcast replay ...Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
... Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction with the ... Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction of the ... from the Investors section on the corporate web site at http://www.sinovac.com . A webcast replay ...Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
... about BIOZONA 2009, please visit the event web site at http://www.azbio.org/Biozona2009.asp . ... Pharmatech Oncology provides services of a site Management Organization (SMO) and a Contract ... Trials, Cancer, Patients, Contract Research, site Management, Data Management, Research, Network, ...Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
... is Innocoll's lead technology platform for the site specific targeted delivery of a wide variety of ... III development for the prevention of surgical site infections in patients or surgeries at higher ... in the US for the prevention of surgical site infections. It is approved for sale in 49 ...NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
... treatment option applied directly to the site of pain, Qutenza can produce up to three months ... Investor Relations section on the corporate web site at http://www.neurogesx.com . A web cast replay can be accessed on the corporate web site beginning March 20, 2009 at the same time as the ...The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
... as a preferred vendor for its Contract Research, site Management, and Data Management services within ... Pharmatech Oncology provides services of a site Management Organization (SMO) and a Contract ... Trials, Cancer, Patients, Contract Research, site Management, Data Management, Research, Network, ...ERT Reports Fourth Quarter and Full Year 2008 Results
... Financial and can be accessed at ERT's web site at www.ert.com . The webcast may also be ... 21,565 21,748 69,547 99,258 site support 6,657 7,500 26,451 ... 8,749 30,522 39,697 Cost of site support 4,665 3,880 17,808 ...Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
... investor section of the Amicus Therapeutics Web site at http://www.amicustherapeutics.com under ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. A telephonic replay of the call ...Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
... investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under Investors: ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. Amicus' press releases are ...SAFC Pharma Augments Assay Development Capabilities
... announcement of a $12 million expansion at the site to construct two fully segregated manufacturing ... capacity within the current 44,000 sq. ft. site and is planned to be Biosafety Level 2 compliant, ... Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com . ...DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant
... device to significantly reduce surgical site infections (SSIs) and potentially save the ... technology designed to mitigate Surgical site Infections (SSIs) in spinal surgery. The ... of stopping biofilm formation in the bone graft site and eliminating 650 types of bacteria including ...Life Sciences Organizations Choose Oracle to Accelerate and Simplify Clinical Trial Data Collection
... needs of trial sponsors as well as investigative site personnel by providing a simplified user interface and eliminating site software installation. This helps to increase ... information about Oracle, please visit our Web site at http://www.oracle.com . Trademarks ...Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
... through Abbott's Investor Relations Web site at http://www.abbottinvestor.com . About ... For more information, visit the company's Web site at http://www.amo-inc.com . About Abbott ... information are available on the company's Web site at http://www.abbott.com . Additional ...Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)
... Draper Labs Acquires Manufacturing site in Tampa Bay The Charles Stark Draper ... St. N., should be completed in March 2009. The site could employ an estimated 65 people in the next ... including the HydroMARK, a breast biopsy site marker that helps patients by replacing lengthy ...